Stock Scorecard
Stock Summary for Sensus Healthcare Inc (SRTS) - $3.33 as of 4/26/2024 3:48:23 PM EST
Total Score
14 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for SRTS
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SRTS
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SRTS
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for SRTS
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for SRTS
Financial Details for SRTS
Company Overview |
|
---|---|
Ticker | SRTS |
Company Name | Sensus Healthcare Inc |
Country | USA |
Description | Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide. The company is headquartered in Boca Raton, Florida. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/9/2024 |
Stock Price History |
|
Last Day Price | 3.33 |
Last Day Price Updated | 4/26/2024 3:48:23 PM EST |
Last Day Volume | 25,173 |
Average Daily Volume | 95,913 |
52-Week High | 5.38 |
52-Week Low | 1.79 |
Last Price to 52 Week Low | 86.03% |
Valuation Measures |
|
Trailing PE | 116.67 |
Industry PE | 48.36 |
Sector PE | 61.73 |
5-Year Average PE | 21.22 |
Free Cash Flow Ratio | 2.36 |
Industry Free Cash Flow Ratio | 61.97 |
Sector Free Cash Flow Ratio | 30.74 |
Current Ratio Most Recent Quarter | 11.76 |
Total Cash Per Share | 1.41 |
Book Value Per Share Most Recent Quarter | 1.57 |
Price to Book Ratio | 1.13 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 2.27 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 16,394,200 |
Market Capitalization | 54,592,686 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 433.30% |
Annual Earnings Growth | -98.00% |
Reported EPS 12 Trailing Months | 0.03 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 0.03 |
Net Income Twelve Trailing Months | 485,000 |
Net Income Past Year | 485,000 |
Net Income Prior Year | 24,244,000 |
Quarterly Revenue Growth YOY | 155.70% |
5-Year Revenue Growth | -1.58% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 23,148,000 |
Total Cash Past Year | 23,148,000 |
Total Cash Prior Year | 25,520,000 |
Net Cash Position Most Recent Quarter | 23,097,000 |
Net Cash Position Past Year | 23,097,000 |
Long Term Debt Past Year | 51,000 |
Long Term Debt Prior Year | 51,000 |
Total Debt Most Recent Quarter | 51,000 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 48,842,000 |
Total Stockholder Equity Prior Year | 48,069,000 |
Total Stockholder Equity Most Recent Quarter | 48,842,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.11 |
MACD Signal | -0.13 |
20-Day Bollinger Lower Band | 1.99 |
20-Day Bollinger Middle Band | 3.41 |
20-Day Bollinger Upper Band | 4.83 |
Beta | 0.94 |
RSI | 44.68 |
50-Day SMA | 3.00 |
200-Day SMA | 5.38 |
System |
|
Modified | 4/25/2024 12:11:06 PM EST |